5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Infections and Inflammatory Heart Diseases
Infections and inflammatory heart diseases can cause significant damage to the heart and its surrounding structures. Conditions such as infective endocarditis, myocarditis, and pericarditis result from bacterial, viral, or fungal infections, leading to inflammation and compromised heart function. Myocarditis, for example, occurs when the heart muscle becomes inflamed due to a viral infection, weakening its ability to pump blood effectively. Inflammatory heart diseases can also arise from autoimmune conditions, where the body's immune system attacks its own tissues, including the heart. Early diagnosis through blood tests, imaging, and clinical evaluation is essential for effective treatment, which may include antibiotics, antivirals, or immunosuppressive therapies. Managing these conditions promptly can reduce the risk of long-term heart damage, including heart failure or valve dysfunction.
John R Doty
Intermountain Medical Center, United States
Trevor Tucker
Dynamic Vascular Resolution Inc., Canada
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Fatima Michelle Villa Jimenez
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico
Mancilla Sandoval Yoana Tenneth
Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Surgical options for aortic valve preservation
John R Doty, Intermountain Medical Center, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina